Effects of Astragalus Extract Mixture and its Effective Components on the Cardiac Function in the Rats with Experimental Heart Failure Induced by Adriamycin
WANG Yu-min, MA Yan-yan, GAO Jun-hong, et al. Effects of Astragalus Extract Mixture and its Effective Components on the Cardiac Function in the Rats with Experimental Heart Failure Induced by Adriamycin[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(7): 208-212.
WANG Yu-min, MA Yan-yan, GAO Jun-hong, et al. Effects of Astragalus Extract Mixture and its Effective Components on the Cardiac Function in the Rats with Experimental Heart Failure Induced by Adriamycin[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(7): 208-212.DOI:
Objective: To investigate the effects of astragalus extract mixture and effective components on the cardiac functions in rat heart failure(HF) induced by adriamycin. Method: Ninety male SD rats were randomized into 7 groups
including control group
HF group
Digoxigein (DG) group
Astragaloside (ASIV) group
astragalus polysaccharide (APS) group
total saponins of astragalus (AST) group and Astragalus Extract Mixture (AEM) group. Twelve rats were used in each of all groups except HF group in which 18 rats were used. The animals in all experimental groups except control group were intra-peritoneally injected with adriamycin(ADM) every other day to produce HF model; the animals in all experimental groups except HF group were respectively treated with intragastric administration of DG
AEM or other effective components aboved at the same time when ADM was given. The drugs dose of DG
ASIV
APS
AST were 0.05
50
1 000
100 and 8 000 mg·kg-1respectively
The dose of Astragalus Extract Mixture in the AEM group is equivalent to the crude herb
Volume of gastric perfusion was 2 mL in the every groups. Survival Rate(SR)
left ventricular systolic pressure(LVSP)
Heart Rate(HR)
+dp/dtmax and T-dp/dtmax were recorded and compared among the all groups. Result: The values of SR
LVSP
HR and +dp/dtmax in HF group were significantly lower than those in all other groups (P<0.01). As compared with HF group
SR
LVSP and +dp/dtmax were significantly enhanced in all experimental groups among which
the indices of cardiac function in AEM group were improved more significantly. Further experiment showed that AEM can also increase HR and shorten T-dp/dtmax in HF rats. Comparatively
the therapeutic effect of AEM in HF rats was even stronger than DG as shown in the present study. The parameters such as LVSP and +dp/dtmax in APS group were improved
so that the therapeutic action of the APS to HF can be demonstrated. Conclusion: Astragalus extract mixture and the effective components of astragalus including ASIV
AST and APS can significantly enhance the survival rate and cardiac contractility in the rats with experimental heart failure. Astragalus extract mixture may be more effective and safer in the treatment of HF. Curative effect of APS to HF is so benificial and significant that can not ignored.